Clinicians Should Learn to Engage With Transgender Patients

Share this content:
Clinicians Should Learn to Engage With Transgender Patients
Clinicians Should Learn to Engage With Transgender Patients

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Clinicians should learn how to engage with transgender patients and be prepared to manage unique clinical issues, according to a review published online Aug. 27 in JAMA Internal Medicine.

Noting that there are an estimated 1.4 million transgender adults in the United States and that this number is increasing, Nicole Rosendale, M.D., from the University of California in San Francisco, and colleagues performed a narrative review to consider issues such as how to address transgender patients, obtaining an inclusive history, and managing clinical issues.

The researchers found that in caring for a transgender patient, best practices include using a patient-identified name and pronoun, using gender-neutral terminology until the appropriate term is identified by the patient, and obtaining a surgical history that includes an anatomic inventory. Disease-specific risk factors can be modified by gender-affirming hormones, and they can confer risk for in-hospital complications and cause changes in laboratory values. Studies are limited to observational studies and case series; some of the data were derived and extrapolated from cisgender populations. Unique systems-based concerns, including lack of procedures for standardized collection of gender identity and lack of sufficiently comprehensive electronic health record platforms, were identified.

"Our goal is to provide practical skills to help clinicians feel comfortable caring for transgender patients, as well as highlight specific steps that institutions can take towards more inclusive systems of care," a coauthor said in a statement.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease

Diagnostic Strategy Can Rule Out PE in Pregnant Women

Diagnostic Strategy Can Rule Out PE in Pregnant ...

Strategy includes clinical probability assessment, D-dimer, lower-limb compression ultrasound, CTPA

is free, fast, and customized just for you!




Already a member?

Sign In Now »